University of Ioannina
Επίδραση της σιλδεναφίλης και του NO σε ασθενείς με δευτεροπαθή πνευμονική υπέρταση
Abstract
dc:descriptionPulmonary hypertension is a chronic disease wich inevitably leads to death. Our goal was to study the effect of inhaled nitirc oxide and per os sildenafil in secondary “out of proportion” PH early after surgery in patients that underwent replacement of the aortic and/or mitral valve (with or without coronary artery bypass graft surgery) and had concomitant left heart failure. Based on our protocol inhaled nitric oxide 10 ppm and per os sildenafil 100 mg were administered. The effect of each drug separately and additively was studied within 90 minutes of its administration and any changes in the pulmonary and systemic circulation parameters and in the blood gas parameters were noted. Twenty patients were studied and were divided into two groups ( ten patients in each group). The two groups were homogeneous as far as their demographics, the admitting diagnosis in ICU and the severity of left heart failure (as this determined by the left ventricular ejection fraction echocardiographically in the early postoperative period ) were concerned. The administered medications were given with a different order in each group. Our results, which are in accordance with existing studies, have revealed a salutary effect of each medication ( separately and additively) in pulmonary circulation with a statistical significant decrease in pulmonary arterial pressure and resistance. In addition it was noted a decrease in systemic arterial pressure and resistance due to the action of sildenafil that was not noted with nitric oxide and it was not magnified by the additive action of the two medications. The cardiac index and the mixed venous oxygen saturation were not affected under all circumstances. The oxygenation index diminished with the administration of sildenafil and returned to baseline value with the addition of nitric oxide. Accordingly, the oxygenation index increased with the action of nitric oxide and returned to baseline value with the administration of sildenafil. The changes in systemic pressure and oxygenation index, despite the fact that they were statistically significant, did not have a clinical impact. No patient was removed from the study because of a serious adverse effect. No deaths were noted that were related to the action of the medications. The administration of inhaled nitric oxide and per os sildenafil to patients with “out of proportion” PH group 2 and left heart failure, who have undergone replacement of the aortic and/or mitral valve with or without coronary artery bypass graft surgery was shown to be safe and effective. Despite of limitations of our study, due to the small size of the study population and the short observation time, the homogeneity of the population and the degree of responsiveness to the administered medications without the emergence of untoward effects, reinforce our results.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Παμπόρη, Σμάρω
- Pampori, Smaro
Subjects
dc:subject × 13- Δευτεροπαθής πνευμονική υπέρταση
- Σιλδεναφίλη και πνευμονική υπέρταση
- Νιτρικό μονοξείδιο και πνευμονική υπέρταση
- Πνευμονική υπέρταση κατηγορίας 2
- Δυσανάλογη πνευμονική υπέρταση κατηγορίας 2
- Πνευμονική υπέρταση και αριστερή καρδιακή ανεπάρκεια
- Σιλδεναφίλη
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29297